The story of Sildenafil presents a interesting case for stakeholders in the pharmaceutical sector. While initially a phenomenal success, creating huge profits, the patent lapse and the subsequent entry of generic https://porn651081.mybloglicious.com/61688978/the-little-copyright-and-pharma-a-risky-bet